Unravelling the Potential of Trans-3-Hydroxycinnamic Acid on Metabolic Indices, Biochemical, and Haematological Parameters in Rats with Metabolic Disturbances
DOI:
https://doi.org/10.31436/imjm.v25i03.3089Keywords:
trans-3-hydroxycinnamic acid, metabolic indices, biochemical, haematological, metabolic disturbanceAbstract
Introduction: Metabolic disturbances caused by high-calorie diets contribute significantly to global mortality. Trans-3-hydroxycinnamic acid (HCA), a bioactive antioxidant, may offer protective effects against such imbalances. This study evaluated the metabolic, biochemical, and haematological effects of HCA in rats fed a high-fat, high-fructose (HFHF) diet. Materials and Methods: Male Sprague Dawley rats aged 7-8 weeks were fed with HFHF diet for 6 consecutive weeks. Rats with metabolic disturbances received HCA at 15 mg/kg, 30 mg/kg, or 60 mg/kg, and were continuously fed with HFHF diet for another 6 weeks. Normal control rats received normal pellets. The effects of HCA on metabolic indices, biochemical, and haematological parameters were evaluated. Results: HCA treatment for 6 weeks ameliorates metabolic indices, including weight gain, Lee obesity index, abdominal and thoracic circumferences, TC/HDL ratio, glucose, and fat pad deposition. Improved AST and ALT levels indicated the hepatoprotective effect of HCA, supported by decreased fat vacuolation. The most significant effects were observed at 30 mg/kg. No significant haematological or renal toxicity was detected. Conclusion: Our results indicated HCA at 30 mg/kg is the optimum dose that exerts its ameliorative effects in reducing metabolic indices, along with no severe biochemical and haematological changes.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
All material submitted for publication is assumed to be submitted exclusively to the IIUM Medical Journal Malaysia (IMJM) unless the contrary is stated. Manuscript decisions are based on a double-blinded peer review process. The Editor retains the right to determine the style and if necessary, edit and shorten any material accepted for publication.
IMJM retain copyright to all the articles published in the journal. All final ‘proof’ submissions must be accompanied by a completed Copyright Assignment Form, duly signed by all authors. The author(s) or copyright owner(s) irrevocably grant(s) to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the research article in its entirety or in part, in any format or medium, provided that no substantive errors are introduced in the process, proper attribution of authorship and correct citation details are given, and that the bibliographic details are not changed. If the article is reproduced or disseminated in part, this must be clearly and unequivocally indicated.
